Page 843 - Read Online

Franco et al. Hepatoma Res 2018;4:74 I http://dx.doi.org/10.20517/2394-5079.2018.94 Page 17 of 18

health and nutrition examination survey 2003 to 2010. Ann Intern Med 2014;160:293-300.
169. Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, et al. The present and future disease burden of hepatitis c virus (HCV) infection
with today’s treatment paradigm. J Viral Hepat 2014;21:34-59.
170. Hepatitis B and C Public Policy Association ASBL. Hepatitis C elimination in Europe - European policy guidelines. Available from:
http://www.hcvbrusselssummit.eu/images/documents/reports/HCV-Elimination-PolicyGuidelines.pdf. [Last accessed on 28 Nov 2018]
171. Arora S, Thornton K, Murata G, Deming P, Kalishman S, et al. Outcomes of treatment for hepatitis C virus infection by primary care
providers. N Engl J Med 2011;364:2199-207.
172. Hill WD, Butt G, Alvarez M, Krajden M. Capacity enhancement of hepatitis C virus treatment through integrated, community-based
care. Can J Gastroenterol 2008;22:27-32.
173. Lloyd AR, Clegg J, Lange J, Stevenson A, Post JJ, et al. Safety and effectiveness of a nurse-led outreach program for assessment and
treatment of chronic hepatitis C in the custodial setting. Clin Infect Dis 2013;56:1078-84.
174. Hill WD, Butt G, Alvarez M, Krajden M. Capacity enhancement of hepatitis C virus treatment through integrated, community-based
care. Can J Gastroenterol 2008;22:27-32.
175. Nazareth S, Kontorinis N, Muwanwella N, Hamilton A, Leembruggen N, et al. Successful treatment of patients with hepatitis C in
rural and remote Western Australia via telehealth. J Telemed Telecare 2013;19:101-6.
176. Beste LA, Glorioso TJ, Ho PM, Au DH, Kirsh SR, et al. Telemedicine specialty support promotes hepatitis C treatment by primary
care providers in the department of veterans affairs. Am J Med 2017;130:432-8.
177. Kattakuzhy S, Gross C, Emmanuel B, Teferi G, Jenkins V, et al. Expansion of treatment for hepatitis C virus infection by task shifting
to community-based nonspecialist providers: a nonrandomized clinical trial. Ann Intern Med 2017;167:311-8.
178. Mera J, Vellozzi C, Hariri S, Carabin H, Drevets DA, et al. Identification and clinical management of persons with chronic hepatitis C
virus infection - Cherokee Nation, 2012-2015. MMWR Morb Mortal Wkly Rep 2016;65:461-6.
179. Hellard M, Sacks-Davis R, Doyle J. Hepatitis C elimination by 2030 through treatment and prevention: think global, act in local
networks. J Epidemiol Community Health 2016;70:1151-4.
180. Centers for Disease Control and Prevention (CDC). Integrated prevention services for HIV infection, viral hepatitis, sexually
transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of
Health and Human Services. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6105a1.htm. [Last accessed on 28 Nov
2018]
181. Scott N, Ólafsson S, Gottfreðsson M, Tyrfingsson T, Rúnarsdóttir V, et al. Modelling the elimination of hepatitis C as a public health
threat in Iceland: a goal attainable by 2020. J Hepatol 2018;68:932-9.
182. European Union HCV Collaborators. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for
elimination in the European Union by 2030: a modelling study. Lancet Gastroenterol Hepatol 2017;2:325-36.
183. Dore GJ, Hajarizadeh B. Elimination of hepatitis C virus in Australia: laying the foundation. Infect Dis Clin North Am 2018;32:269-79.
184. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public
Health Practice; Committee on a National Strategy for the Elimination of Hepatitis B and C. Modeling the Elimination of Hepatitis
C in the United States. In: Strom BL, Buckley GJ, editors. A National Strategy for the Elimination of Hepatitis B and C: Phase Two
Report. Washington (DC): National Academies Press (US); 2017.
185. Suryaprasad AG, White JZ, Xu F, Eichler BA, Hamilton J, et al. Emerging epidemic of hepatitis C virus infections among young
nonurban persons who inject drugs in the United States, 2006-2012. Clin Infect Dis 2014;59:1411-9.
186. Holmberg SD, Spradling PR, Moorman AC, Denniston MM. Hepatitis C in the United States. N Engl J Med 2013;368:1859-61.
187. Belperio PS, Chartier M, Gonzalez RI, Park AM, Ross DB, et al. Hepatitis C care in the department of veterans affairs: building a
foundation for success. Infect Dis Clin North Am 2018;32:281-92.
188. HHS.gov. The community response to viral hepatitis - contributions towards achieving the goals of the viral hepatitis action plan.
Available from: https://www.hhs.gov/hepatitis/action-plan/viral-hepatitis-community-action/community-response-to-viral-hepatitis/
index.html. [Last accessed on 29 Nov 2018]
189. Waked I, Doss W, El-Sayed MH, Estes C, Razavi H, et al. The current and future disease burden of chronic Hepatitis C virus infection
in Egypt. Arab J Gastroenterol 2014;15:45-52.
190. The World Bank. Treatment program policy analysis 2017 (English). Available from: http://documents.worldbank.org/curated/
en/335981517329520478/Treatment-program-policy-analysis-2017. [Last accessed on 28 Nov 2018]
191. The World Bank. Eliminating hepatitis C from Egypt: 2017 update on current trends and policyrecommendations - policy brief
(English). Available from: http://documents.worldbank.org/curated/en/164381517333701631/Eliminating-Hepatitis-C-from-Egypt-
2017-update-on-current-trends-and-policyrecommendations-policy-brief. [Last accessed on 28 Nov 2018]
192. Mitruka K, Tsertsvadze T, Butsashvili M, Gamkrelidze A, Sabelashvili P, et al. Launch of a nationwide hepatitis C elimination
program - Georgia, April 2015. MMWR Morb Mortal Wkly Rep 2015;64:753-7.
193. Gvinjilia L, Nasrullah M, Sergeenko D, Tsertsvadze T, Kamkamidze G, et al. National progress toward hepatitis C elimination -
Georgia, 2015-2016. MMWR Morb Mortal Wkly Rep 2016;65:1132-5.
194. Nasrullah M, Sergeenko D, Gvinjilia L, Gamkrelidze A, Tsertsvadze T, et al. The role of screening and treatment in national progress
toward hepatitis C elimination - Georgia, 2015-2016. MMWR Morb Mortal Wkly Rep 2017;66:773-6.
195. WHO. Brazil sets out path to eliminate hepatitis C by 2030. Available from: http://www.worldhepatitissummit.org/docs/default-
source/press-releases/government-of-brazil/brazil-sets-out-path-to-eliminate-hepatitis-c-by-2030.pdf?sfvrsn=2. [Last accessed on 28
Nov 2018]
196. Leidner AJ, Chesson HW, Xu F, Ward JW, Spradling PR, et al. Cost-effectiveness of hepatitis C treatment for patients in early stages
of liver disease. Hepatology 2015;61:1860-9.
197. Harris RJ, Martin NK, Rand E, Mandal S, Mutimer D, et al. New treatments for hepatitis C virus (HCV): scope for preventing liver
disease and HCV transmission in England. J Viral Hepat 2016;23:631-43.